RIOL3 promoted the proliferation and survival of gliomas through the AKT/mTOR signaling pathway [44] In our study, we identified the phosphorylation of AKT and mTOR inactivated in ARG-treated glioma cells. This evidence concerns the gene MTOR and central nervous system cancer.